Fesoterodine

WikiDoc Resources for Fesoterodine
Articles
Most recent articles on Fesoterodine Most cited articles on Fesoterodine Review articles on Fesoterodine Articles on Fesoterodine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fesoterodine Images of Fesoterodine Photos of Fesoterodine Podcasts & MP3s on Fesoterodine Videos on Fesoterodine
Evidence Based Medicine
Cochrane Collaboration on Fesoterodine Bandolier on Fesoterodine TRIP on Fesoterodine
Clinical Trials
Ongoing Trials on Fesoterodine at Clinical Trials.gov Trial results on Fesoterodine Clinical Trials on Fesoterodine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fesoterodine NICE Guidance on Fesoterodine NHS PRODIGY Guidance FDA on Fesoterodine CDC on Fesoterodine
Books
Books on Fesoterodine
News
Fesoterodine in the news Be alerted to news on Fesoterodine News trends on Fesoterodine
Commentary
Blogs on Fesoterodine
Definitions
Definitions of Fesoterodine
Patient Resources / Community
Patient resources on Fesoterodine Discussion groups on Fesoterodine Patient Handouts on Fesoterodine Directions to Hospitals Treating Fesoterodine Risk calculators and risk factors for Fesoterodine
Healthcare Provider Resources
Symptoms of Fesoterodine Causes & Risk Factors for Fesoterodine Diagnostic studies for Fesoterodine Treatment of Fesoterodine
Continuing Medical Education (CME)
CME Programs on Fesoterodine
International
Fesoterodine en Espanol Fesoterodine en Francais
Business
Fesoterodine in the Marketplace Patents on Fesoterodine
Experimental / Informatics
List of terms related to Fesoterodine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The antimuscarinic Fesoterodine is a drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome. It was recommended for approval by the European Medicines Agency in February 2007, but is not yet available for use.